**Education and Professional Experience:** Graduated with a Bachelor's degree from Jiangxi Medical College in 1985, a Master's degree from Sun Yat-sen University in 1996, and a Doctorate from Sun Yat-sen University in 2004. Conducted oncology research at McGill University, Canada in 2002. Completed a clinical observership in Surgical Oncology at UT Southwestern Medical Centre, USA in 2012. Served as Resident Physician and Attending Surgeon in Surgery at Yichun District Hospital, Jiangxi from 1985 to 1993. Served as Attending Physician and Associate Chief Physician in General Surgery at Guangzhou Development District Hospital from 1996 to 2000. Worked as a Visiting Scholar at McGill University, Canada from 2002 to 2005. Has served as Associate Chief Physician and Chief Physician in the Department of Hepatobiliary Surgery at the First Affiliated Hospital of Sun Yat-sen University from 2005 to present. **Professional Affiliations:** Member of the Chinese Medical Doctor Association, Standing Committee Member of the Biliary and Pancreatic Disease Branch of the Guangdong Liver Disease Association, Standing Committee Member of the Liver Surgery Branch of the Guangdong Liver Disease Association, Editorial Board Member of the Journal of Digestive Oncology. **Publications:** Authored multiple papers in domestic and international journals. 1. Naciba Benlimame, Qiang He, Su Jie, Dingzhang Xiao, Ying Jie Xu, Martin Loignon, David D. Schlaepfer, and Moulay A. Alaoui-Jamali. FAK signaling is critical for ErbB2/ErbB3 receptor cooperation for oncogenic transformation and invasion. Journal of Cell Biology, 2005 Nov 7; 171(3): 505-16. (Co-first author) 2. Alaoui-Jamali MA, Qiang H. The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery. Drug Resist Updat. 2003 Apr;6(2):95-107. 3. Alaoui-Jamali MA, Dupré I, Qiang H. Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling. Drug Resist Updat. 2004 Aug-Oct;7(4-5):245-55. 4. Xu Y, Benlimame N, Su J, He Q, Alaoui-Jamali MA. Regulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells. Br J Cancer. 2009 Feb 24;100 (4):633-43. Epub 2009 Feb 3. 5. A Liya, Lin Wu, He Qiang (Corresponding Author). Construction of FAK-shRNA recombinant retroviral vector and screening of stable expression cell lines. Chinese Journal of Pathophysiology. 2011, 27(4):688-694. 6. He Qiang, Liang Lijian, Peng Baogang, Li Shaoqiang, Tang Di, A Liya. ErbB2 induces cell transformation, migration, and invasion via the FAK-Src-MAPK signaling pathway. Chinese Journal of Pathophysiology. 2008, (12):2363-2365. 7. He Qiang, Huang Meijin, Peng Baogang, Liang Lijian, Shen Shunli, Zhou Fan. ErbB2-induced tumor formation and invasion depend on FAK function. Chinese Journal of Pathophysiology, 2007, 23 (12):2369-2373. 8. Peng Baogang, He Qiang, Liang Lijian. Overexpression of ErbB2 promotes MCF-7 cell growth and invasion in vitro. Chinese Journal of Pathophysiology, 2005, 21(8):1566-1568. 9. HE Qiang, PENG Bao-gang, LIANG Li-jian. Overexpression of ErbB2 in MCF-7 is sufficient to promote cell growth and invasion. China Journal of Modern Medicine. 2005, 6: 818-821, 827. 10. He Qiang, Liang Lijian. Discussion on surgical indications and timing for severe acute pancreatitis. Chinese Journal of General Surgery. 2001, 16(2):106-107. 11. Peng Baogang, Luo Shimin, Liang Lijian, He Qiang. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. Chinese Journal of Practical Surgery. 2002, 22(9):527-529. 12. Peng Baogang, Liang Lijian, He Qiang, Ding Jian, et al. Experimental study of tumor necrosis factor combined with interferon gamma in the treatment of primary liver cancer. Chinese Journal of Hepatobiliary Surgery. 2003; 9(1):25. 13. Peng Baogang, Liang Lijian, He Qiang, Huang Jiefu, Lv Mingde. Tumor vaccine therapy using cytokine sustained-release agents. Chinese Journal of Experimental Surgery. 2003; 20(Suppl):1-3. 14. Peng Baogang, Liang Lijian, He Qiang, Huang Jiefu, Lv Mingde. Tumor vaccine therapy using cytokine sustained-release agents. Chinese Journal of Experimental Surgery. 2003; 20(Suppl):1-3. 15. He Qiang, Liang Lijian, Peng Baogang, Yin Xiaoyu, et al. Risk analysis of surgical resection for large hepatocellular carcinoma. Chinese Journal of General Surgery. 2004; 19(4):197-199. 16. Peng Baogang, Liang Lijian, He Qiang, Li Meisheng. Changes in peripheral blood lymphocyte subsets in patients with primary liver cancer. Chinese Journal of Clinical Oncology. 2004; 31(11):648-649. 17. He Qiang, Liang Lijian. Efficacy analysis of devascularization for portal hypertension. Chinese Journal of General Surgery. 2005; 20(4):221-223. 18. He Qiang, Peng Baogang, Liang Lijian. Significance of ErbB2 overexpression in MCF-7 cells (English). China Journal of Modern Medicine. 2005; 15(6):818-827. 19. Peng Baogang, He Qiang, Liang Lijian. Overexpression of ErbB2 promotes MCF-7 cell growth and invasion in vitro. Chinese Journal of Pathophysiology. 2005; 21(8):1566-1568. 20. Peng Baogang, Liang Lijian, He Qiang. Study on anti-hepatocellular carcinoma immunity induced by autologous tumor immune activator. Journal of Sun Yat-sen University (Medical Sciences). 2005; 26(3) Suppl:43-44. 21. Peng Baogang, Liang Lijian, He Qiang, Kuang Ming. Tumor vaccine against recurrence of hepatocellular carcinoma. World J Gastroenterol. 2005; 11(5):700-704. 22. He Qiang, Liang Lijian, Shen Shunli. Surgical treatment of 68 cases of Caroli's disease. Chinese Journal of Surgery. 2006, 44(23):1617-1619. 23. He Qiang, Peng Baogang, Liang Lijian. Surgical risk of major hepatectomy for hepatocellular carcinoma with cirrhosis (English). China Journal of Modern Medicine. 2006, 16(1):1-4. 24. Peng Baogang, He Qiang, Liang Lijian, et al. Induction of cytotoxic T-lymphocyte responses using dendritic cells transfected with hepatocellular carcinoma mRNA. Br J Biomed Sci. 2006; 63(3):123-8. 25. Peng Baogang, Liang Lijian, He Qiang. Surgical Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Hepato-Gastroenterology. 2006; 53:415-419. 26. Peng Baogang, Liang Lijian, He Qiang. Experimental study of tumor vaccine using cytokine sustained-release microspheres for hepatocellular carcinoma. Chinese Journal of Pathophysiology. 2006, 22(6):1235-1237. 27. Peng Baogang, He Qiang. Clinicopathological features, diagnosis, and treatment progress of cholangiocarcinoma at different sites. Chinese Journal of Practical Surgery. 2007, 27(5):414-418. 28. Tang Di, He Qiang, Guo Yu. Diagnosis and treatment analysis of 39 cases of focal nodular hyperplasia of the liver. Chinese Archives of General Surgery. 2007, 1(3). 29. He Qiang, Liang Lijian (Corresponding Author). Several issues in the surgical treatment of hilar cholangiocarcinoma. Chinese Journal of Bases and Clinics in General Surgery. 2009, 16(11):869-872. 30. Peng Baogang, He Qiang, Shen Shunli, Liang Lijian (Corresponding Author), et al. Hepatectomy combined with intraoperative thermal ablation for multifocal primary liver cancer. Chinese Journal of Surgery. 2009, 47(23):1767-1770. 31. Peng Baogang, He Qiang, Xu Ming, Ye Xiaoming (Corresponding Author), et al. Hyperthermia combined with intratumoral injection of wild-type p53 for hepatocellular carcinoma. Chinese Journal of Experimental Surgery. 2009, 26(3):392-393. **Other Major Work Achievements (